Hoenle AG Poised for Growth Amid Strategic Shifts

Hoenle AG, under analysis by NuWays AG, is projected to follow its FY guidance for 2024/25 and expand in the following year. The company is anticipated to hit sales of €93 million and an EBITDA of €5.8 million, aligning with expectations. This performance reflects Hoenle's strategic adaptation and seasonal sales behavior, despite challenges from cautious market ordering.

Looking ahead to FY25/26, Hoenle is expected to achieve an 8% sales growth, reaching around €100 million. Key to this growth is the expansion of its Disinfection business, which saw a 6% rise in 2024/25. Innovations in products such as LED-based UV curing and ultra-pure water are gaining momentum. Margin improvement is expected, supported by an enhanced product mix and recent cost-saving measures, although initial expenses for new products might slow progress.

In summary, Hoenle AG's mid- to long-term outlook remains promising with a strategic transformation underway, reinforcing the company's potential for sustainable growth.